What are the South African guidelines for managing a breakthrough seizure in a patient with epilepsy who is already on chronic antiepileptic therapy?

Management of Breakthrough Seizures in Epileptic Patients on Treatment in South Africa

For a patient with epilepsy on chronic antiepileptic therapy who experiences a breakthrough seizure, immediately assess for reversible precipitants (medication non-adherence, drug interactions, sleep deprivation, alcohol use, intercurrent illness, metabolic derangements), optimize the current antiepileptic drug (AED) regimen by checking serum levels and adjusting dosing, and arrange urgent follow-up with their treating physician or neurologist within 48-72 hours rather than making empiric medication changes in the emergency setting.

Initial Assessment and Stabilization

When an epileptic patient on treatment presents with a breakthrough seizure, your first priority is determining whether this represents:

• A single self-limited seizure that has already terminated
• Ongoing seizure activity requiring acute intervention
• Status epilepticus (continuous seizure >5 minutes or recurrent seizures without return to baseline)

If Actively Seizing or Status Epilepticus

Follow standard status epilepticus protocols 1:

First-line treatment:

• Lorazepam 0.1 mg/kg IV (maximum 2 mg), may repeat once after 1 minute 2
• Assess airway, breathing, circulation; provide high-flow oxygen
• Check blood glucose immediately

Second-line treatment (if seizures persist after benzodiazepines):

• Administer IV phenytoin, fosphenytoin, or valproate 1
• Phenytoin: 18-20 mg/kg IV at maximum rate of 50 mg/min
• Fosphenytoin: 18-20 PE/kg IV at maximum rate of 150 PE/min
• Valproate: 20-30 mg/kg IV at rate of 40 mg/min

The 2024 ESETT trial demonstrated equivalent efficacy between levetiracetam, fosphenytoin, and valproate for status epilepticus (all approximately 45-47% success rate), so any of these agents is acceptable 3. Valproate has the advantage of faster administration with fewer cardiovascular side effects compared to phenytoin 1.

Identifying Precipitants of Breakthrough Seizures

The most critical step is systematically identifying why seizure control was lost 4:

Medication-Related Factors

• Non-adherence (most common cause): Directly ask about missed doses, financial barriers to obtaining medications, or intentional discontinuation
• Subtherapeutic drug levels: Check serum levels of current AED if available
• Drug interactions: New medications (antibiotics, antifungals, antiretrovirals particularly relevant in South Africa) that induce or inhibit hepatic metabolism
• Incorrect dosing: Verify current dose against therapeutic range for patient's weight

Physiological Precipitants

• Sleep deprivation: Specifically quantify hours of sleep in past 48 hours
• Alcohol use or withdrawal: Common trigger, particularly binge drinking patterns
• Intercurrent illness: Fever, systemic infection, dehydration
• Metabolic derangements: Hyponatremia, hypoglycemia, hypocalcemia, uremia

Structural/Progressive Causes

• New structural lesion: Consider imaging if new focal features, persistent altered mental status, or focal neurological deficits
• Tumor progression in patients with known brain lesions
• Post-stroke changes in vascular epilepsy patients

Management Strategy for the Breakthrough Seizure

Do NOT Routinely Load with Additional AEDs

There is insufficient evidence to support routine loading with antiepileptic medications in the emergency department for patients who have stopped seizing and are already on chronic AED therapy 1. The choice between oral and parenteral administration does not affect early seizure recurrence rates in patients with known seizure disorders 1.

Instead, Focus on Optimization

Check serum drug levels (if available) of the patient's current AED:

• If subtherapeutic: Increase maintenance dose or give supplemental dose to achieve therapeutic range
• If therapeutic: The current regimen is inadequate and requires neurologist consultation for medication adjustment

Address identified precipitants:

• Reinforce adherence strategies if non-compliance identified
• Discontinue or adjust interacting medications
• Treat underlying infection, correct metabolic abnormalities
• Counsel on sleep hygiene and alcohol avoidance

South African Context Considerations

Given the specific challenges in rural South Africa 5:

Medication access and affordability:

• Verify the patient can actually obtain and afford their prescribed AED
• Consider switching to more accessible alternatives if supply chain issues exist
• Connect patient with social services for medication assistance programs

Healthcare system barriers:

• Many patients have limited access to neurologists or specialized epilepsy care 5
• Emergency physicians must be comfortable with basic AED management
• Establish clear follow-up plan with primary care physician who can coordinate ongoing care

Side effect burden:

• Significant proportion of South African patients with epilepsy report recurring side effects leading to non-adherence 5
• Directly ask about tolerability of current regimen
• Document side effects for treating physician to consider alternative agents

Disposition and Follow-Up

Discharge criteria:

• Seizure has terminated
• Patient returned to neurological baseline
• Reversible precipitant identified and addressed
• Patient has adequate supervision at home
• Follow-up arranged within 48-72 hours

Mandatory follow-up communication 4:

• Contact patient's treating physician (neurologist or primary care) before discharge
• Document: seizure characteristics, duration, precipitants identified, interventions performed, current AED levels if obtained
• Schedule specific follow-up appointment (not just "follow up with your doctor")
• Provide written discharge instructions including seizure precautions

Admission criteria:

• Status epilepticus requiring ongoing treatment
• Multiple recurrent seizures in ED
• Persistent altered mental status
• New focal neurological deficits suggesting structural lesion
• Significant injury from seizure
• Inadequate home supervision
• Suspected non-epileptic etiology requiring further workup

Common Pitfalls to Avoid

Do not empirically add a second AED without consulting neurology or the patient's treating physician. This creates polypharmacy risks and makes it difficult to determine which medication is effective.

Do not assume non-adherence is the only cause. While common, systematically evaluate for other precipitants including drug interactions (particularly antiretrovirals in South Africa's high HIV prevalence population) and metabolic causes.

Do not discharge without concrete follow-up plan. The continuity between emergency care and ongoing epilepsy management is critical 4. Patients lost to follow-up after breakthrough seizures have worse long-term outcomes.

Do not overlook the social determinants. In South Africa, medication access, affordability, education level, and healthcare system navigation significantly impact epilepsy control 5. Address these barriers explicitly.